Monoclonal antibody treatment for COVID-19 could be a game changer: Dr Nageshwar
The Asian Institute of Gastroenterology (AIG) in Hyderabad is conducting one of the most significant studies to see if the therapy works against the highly contagious Delta variant of Covid-19. According to AIG Chairman Dr Nageshwar Reddy, covid patients with mild to moderate symptoms recovered within two to three days.
He stated that 50 covid patients were administered a special drug cocktail of monoclonal antibodies comprising Casirivimab and Imdevimab and they recovered within a short time. "The drug cocktail is usually advised for patients crossing 60 years and is used for mild to moderate corona cases, and it costs around Rs 70,000," he mentioned.